• Normalization of Abnormal Blood Pressure in Patients Undergoing Jugular Balloon Dilation

    Michael Arata, MD1;Prabhjot (Nina) Grewal, MD1; Steven Cen, PhD2; Frances DeBarge-Igoe, RN1. 1Synergy Health Concepts, Newport Beach, CA 2USC Dept of Biokinesiology and Physical Therapy PURPOSE: to evaluate the changes in blood pressure that occur following jugular vein balloon dilation in patients exhibiting symptomatic autonomic dysfunction. MATERIALS AND METHODS: a retrospective chart review was performed […]

  • Prevalence of Symptomatic Dysautonomia in Patients Presenting for CCSVI Treatment

    M. ARATA1, S. Cen2; BACKGROUND: The FDA recently stated, “the criteria used to diagnose CCSVI have not been adequately established. Therefore, data to support CCSVI as a clinical entity on its own or its relationship with MS are inconclusive and at times, contradictory.” Patients seeking treatment for CCSVI present with a number of symptoms that […]

  • Quantitative Magnetic Resonance Venography in MS Patients

    EM Haacke1,2, PhD, D Utriainen1, BS, S Sethi1, MS, W Feng2, PhD, JJ Hewett3, MD, M Arata3, MD 1MR Innovations, 2Wayne State University, 3Pacific Interventionalists INTRODUCTION: Quantitative imaging of CCSVI using magnetic resonance imaging (MRI) provides an opportunity to study not just anatomical abnormalities1-8 but also the ability to quantify flow2,3,4,7,9. These two pieces of […]

  • Society of Interventional Radiology Responds to FDA Safety

    Society of Interventional Radiology Responds to FDA Safety Communication on Chronic Cerebrospinal Venous Insufficiency Treatment in Multiple Sclerosis Patients On May 10, the Food and Drug Administration issued a medical alert noting that individuals with multiple sclerosis should be aware of the risks of serious injuries and death associated with treatments for chronic cerebrospinal venous […]


    For Immediate Release: May 10, 2020 Media Inquiries: Michelle Bolek, 301-796-2973, [email protected] Consumer Inquiries: 888-INFO-FDA FDA issues alert on potential dangers of unproven treatment for multiple sclerosis The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation […]

  • Dr. Hewett Referenced in Canadian Parliament

    On February 15, Carolyn Bennett read bill C-280 to the Members of Parliament. Bill C-280 is an act to establish a national strategy for CCSVI. In Bennett’s discussion, she mentioned Dr. Hewett on several occasions as a leader in the field. Bennett is a Member of Canadian Parliament and is working diligently to pave the […]

  • Synergy’s Research Efforts Published in Medical Journal

    Dr. Hewett and a team of renowned industry experts, including Dr. Haacke, were published this month in the Journal of Vascular and Interventional Radiology. Two hundred subjects with Multiple Sclerosis from two sites were evaluated with magnetic resonance imaging to quantify blood flow. The MS population was divided into two groups: those with evident internal […]

  • Pacific Medical Innovations - Newport Beach, CA

    Synergy Health Concepts takes pride in offering state-of-the-art facilities and top-of-the-line care for our patients. Undergoing any type of medical procedure can be a stressful and anxiety-provoking experience for anyone, especially when travelling abroad for it. We understand this and want to provide our patients with every comfort and security possible. We will soon be […]

Proud Members of: